Cargando…
An Aggressive Clinical Presentation of Familial Leiomyomatosis Associated with a Fumarate Hydratase Gene Variant of Uncertain Clinical Significance
Autores principales: | SCARFÌ, Federica, OROZCO, Ana Paula, VISCONTI, Alessia, BATAILLE, Veronique |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Society for Publication of Acta Dermato-Venereologica
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9199906/ https://www.ncbi.nlm.nih.gov/pubmed/32556350 http://dx.doi.org/10.2340/00015555-3573 |
Ejemplares similares
-
Cutaneous and uterine leiomyomatosis and ovarian cystadenoma associated with deficiency of fumarate hydratase
por: Hüller, Cornelia, et al.
Publicado: (2011) -
Fumarate hydratase inactivation in hereditary leiomyomatosis and renal cell cancer is synthetic lethal with ferroptosis induction
por: Kerins, Michael J., et al.
Publicado: (2018) -
Rare variant in the fumarate hydratase gene found in patients with clinical features of hereditary leiomyomatosis and renal cell cancer (HLRCC): A case series
por: Franke, Keith, et al.
Publicado: (2022) -
Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
por: Gunnala, Vinay, et al.
Publicado: (2018) -
Fumarate hydratase c.914T > C (p.Phe305Ser) is a pathogenic variant associated with hereditary leiomyomatosis and renal cell cancer syndrome
por: Breen, Kelsey E., et al.
Publicado: (2020)